Drugs & Entheogens

This archive covers progress in drug policy reform, psychedelic-assisted therapy, harm reduction, and the science behind entheogenic substances. From clinical trials to legal milestones, these stories track how researchers, policymakers, and communities are rethinking humanity’s relationship with mind-altering compounds.

|matthew t rader Y MzYPOLkXI unsplash, for article on overdose deaths

Overdose deaths in the United States drop for first time in two decades

Overdose deaths in the United States finally reversed course in 2018, ending nearly two decades of almost unbroken annual increases — a sign that the coordinated public health response is starting to work. Expanded naloxone access, medication-assisted treatment, and community outreach all appear to have contributed, though no single intervention gets the credit. The picture inside the data is mixed: while opioid deaths fell, deaths involving cocaine and methamphetamine rose, suggesting the epidemic shifted rather than ended. Still, experts say this is evidence that scaling up treatment saves lives — and that doing so remains the central, unfinished challenge.